The Blepharitis Drug Market is poised for steady expansion. Valued at USD 1.16 billion in 2024, the market is projected to reach USD 1.71 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.00% from 2025 to 2032. This article explores market dynamics, segmentation, drivers, challenges, and competitive landscape, drawing exclusively from Data Bridge Market Research to...